Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Total Debt: 2011-2025

Historic Total Debt for Mimedx Group (MDXG) over the last 10 years, with Sep 2025 value amounting to $18.2 million.

  • Mimedx Group's Total Debt fell 12.76% to $18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year decrease of 12.76%. This contributed to the annual value of $18.8 million for FY2024, which is 61.65% down from last year.
  • As of Q3 2025, Mimedx Group's Total Debt stood at $18.2 million, which was down 1.34% from $18.5 million recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Total Debt ranged from a high of $49.1 million in Q4 2023 and a low of $18.2 million during Q3 2025.
  • Over the past 3 years, Mimedx Group's median Total Debt value was $20.4 million (recorded in 2024), while the average stood at $30.1 million.
  • As far as peak fluctuations go, Mimedx Group's Total Debt grew by 1.04% in 2023, and later plummeted by 61.65% in 2024.
  • Mimedx Group's Total Debt (Quarterly) stood at $48.1 million in 2021, then rose by 0.97% to $48.6 million in 2022, then grew by 1.04% to $49.1 million in 2023, then slumped by 61.65% to $18.8 million in 2024, then dropped by 12.76% to $18.2 million in 2025.
  • Its last three reported values are $18.2 million in Q3 2025, $18.5 million for Q2 2025, and $18.7 million during Q1 2025.